Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Why do men who receive finasteride have an increased prevalence of high-grade prostate cancer?

Nature Clinical Practice Urology volume 5, pages 130–131 (2008)Cite this article

boxed-textLucia MS et al. (2007) Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst 99: 1375–1383

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Marberger M et al. (2003) The clinical implications of the prostate cancer prevention trial. BJU Int 92: 667–671

    Article  CAS  Google Scholar 

  2. Akduman B and Crawford ED (2006) The PCPT: new findings, new insights, and clinical implications for the prevention of prostate cancer. Eur Urol Suppl 5: 634–639

    Article  CAS  Google Scholar 

  3. Lucia MS (2006) Do 5α-reductase inhibitors alter prostate cancer detection and what are the implications. Eur Urol Suppl 5: 752–757

    Article  CAS  Google Scholar 

  4. Kulkarni GS et al. (2006) Evidence for a biopsy derived grade artifact among larger prostate glands. J Urol 175: 505–509

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. and Head of Department, and T Page is a Specialist Registrar in Urology at the Department of Urology, D Greene is a Professor, a Consultant Urological Surgeon, Sunderland Royal Hospital, Sunderland, UK.,

    Damian Greene & Tobias Page

Authors
  1. Damian Greene
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tobias Page
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Damian Greene.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greene, D., Page, T. Why do men who receive finasteride have an increased prevalence of high-grade prostate cancer?. Nat Rev Urol 5, 130–131 (2008). https://doi.org/10.1038/ncpuro1041

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1041

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing